Technical Analysis for NLAB - Nuoncology Labs Inc

Grade Last Price % Change Price Change
grade C 0.0119 19.00% 0.0019
NLAB closed up 19.0 percent on Friday, July 31, 2020, on 0 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical NLAB trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 19.00%
Fell Below 50 DMA Bearish 19.00%
MACD Bearish Centerline Cross Bearish 19.00%
Wide Bands Range Expansion 19.00%
Older signals for NLAB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NuOncology Labs, Inc. is a development stage company engaged in the cancer research & clinical testing laboratories industries. In its pharmaceutical research NuOncology Labs engages in research, development, testing and licensing of promising pharmaceuticals and other cancer treatments. In its clinical laboratory business, the Company conducts predictive drug response tests for the optimization of chemotherapeutic cancer treatment of individual cancer patients and provides other contracted clinical testing services. Currently, the Company's subsidiaries, Paracure and IPRLL, have four issued patents and three additional allowed patent applications. Additionally, the subsidiaries have four U.S. and 12 international pending patent applications directed to various chemotherapy compounds and methods of cancer treatment.
Medicine Health Cancer Pharmaceuticals Pharmaceutical Industry Pharmaceutical Industry In China Chemotherapy Cancer Treatment Pharmaceutical Research National Cancer Institute Cancer Research

Is NLAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.029
52 Week Low 0.001
Average Volume 27,239
200-Day Moving Average 0.0000
50-Day Moving Average 0.0114
20-Day Moving Average 0.0117
10-Day Moving Average 0.0098
Average True Range 0.0028
ADX 8.89
+DI 42.0792
-DI 40.3465
Chandelier Exit (Long, 3 ATRs ) 0.0084
Chandelier Exit (Short, 3 ATRs ) 0.0142
Upper Bollinger Band 0.0185
Lower Bollinger Band 0.0049
Percent B (%b) 0.51
BandWidth 116.2393
MACD Line 0.0001
MACD Signal Line 0.0002
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0119
Resistance 3 (R3) 0.0119 0.0119 0.0119
Resistance 2 (R2) 0.0119 0.0119 0.0119 0.0119
Resistance 1 (R1) 0.0119 0.0119 0.0119 0.0119 0.0119
Pivot Point 0.0119 0.0119 0.0119 0.0119 0.0119
Support 1 (S1) 0.0119 0.0119 0.0119 0.0119 0.0119
Support 2 (S2) 0.0119 0.0119 0.0119 0.0119
Support 3 (S3) 0.0119 0.0119 0.0119
Support 4 (S4) 0.0119